Elixinol Global Limited — Cyborg Score 3/10

Challenged
Hemp-derived CBD and plant-based nutraceutical products

Strategic Profile

In Australia, Elixinol operates a vertically integrated business producing and distributing products across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. Products are sold under brands including Hemp Foods Australia, The Healthy Chef, Mt Elephant, and Soul Seed. The company maintains dual geographic focus with Australian vertical integration and Americas-based branded nutraceutical operations.

Cyborg Score Rationale

As of June 2026, market cap stands at A$2.9 million. The company shows negative TTM earnings per share of -0.022. The company faces significant valuation pressure and profitability challenges despite multi-brand portfolio and geographic diversification.

Top Insights

  • Stock price trading at A$0.007 (as of June 2026).
  • Operates vertically integrated Australian business with four product verticals and multiple consumer brands across grocery, wholesale and e-commerce.
  • Americas operations focused on Elixinol branded hemp and plant-derived nutraceutical and skincare products.
  • Rebranded from Elixinol Global Limited to Elixinol Wellness Limited in May 2021 to reflect broader wellness positioning.

Named Competitors

  • Cann Group CBD Products — Australian cannabis producer with CBD focus
  • Hemp & CBD Supplements — Hemp-derived CBD wellness products (US-based)
  • Nutritional Supplements & Plant-Based Nutraceuticals — Established Australian nutritional supplement leader

Recent Developments

  • (June 2026) Market cap at A$2.9M with stock trading at A$0.007
  • (February 2026) Director shareholding updates reported
  • Prescription-basis availability achieved for CBD products in New Zealand

Open the full interactive Elixinol Global Limited report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →